Core C - Clinical Trials
Core C - Clinical Trials
批准号:
10240535
负责人:
JOHN M. BUATTI
金额:
$17.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-19 至 2023-08-31
关键词:
AdherenceAdverse eventAnnual ReportsAscorbic AcidBiological MarkersCase Report FormChemotherapy and/or radiationClinicalClinical Cancer CenterClinical DataClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesCodeComplementComplexComprehensive Cancer CenterDataDevelopmentDoseEducationEligibility DeterminationEnsureEthicsGlioblastomaHumanHuman Subject ResearchInfrastructureInfusion proceduresInstitutional Review BoardsInstructionInvestigational DrugsInvestigational New Drug ApplicationIowaLungMalignant neoplasm of lungMalignant neoplasm of pancreasManuscriptsMetabolismMonitorNon-Small-Cell Lung CarcinomaOxidation-ReductionPancreasParticipantPatientsPeer ReviewPharmacologic AscorbatePhasePhase I/II TrialPreparationPrincipal InvestigatorProceduresProcessProtocols documentationPublicationsRadiationRadiation OncologyRadiation therapyReportingResearchResearch PersonnelResourcesSafetySamplingSiteStructureTrainingTraining ProgramsUniversitiesadverse outcomeascorbatebasebiomarker evaluationcancer therapychemotherapydesignexperiencegemcitabineimprovedin vivoinsightiron metabolismnovel therapeutic interventionpatient derived xenograft modelphase I trialphase II trialpreclinical studypredicting responseprogramsrecruitscreeningstandard of caretherapy outcometrial design
中文摘要
项目总结/摘要 - 核心 C:
核心 C 将提供经验丰富、训练有素的临床试验人员,专门从事转化、
涉及药理学抗坏血酸(P-AscH-)的临床研究。这组临床研究人员已
过去 10 年进行临床试验,并已启动并完成了 1 期和 2 期试验
P-AscH-与胰腺、肺和 GBM 受试者的放疗和/或化疗相结合。核心C将
使用 P-AscH- 启动、进行和完成复杂人类受试者研究的各个方面,这些研究是
项目 1 和 2 中提出。核心 C 还将与核心 B 连接,用于患者样本采集和
处理、生物标志物评估以及为参与的工作人员建立结构化培训计划
在每项临床试验研究工作中。该培训计划将包括如何审查流程的指导
资格确定以及抗坏血酸治疗输注的审查(包括给药、审查
和禁忌症)和不良事件报告。此外,Core C 将提供专家指导和
资源以及与霍顿综合癌症中心临床试验基础设施的接口[(即,
方案审查和监测委员会 (PRMC)/数据和安全监测委员会 (DSMC)] 确定
并报告所有关键研究数据,并设计电子病例报告表以获取完整的数据,并
确保向 FDA 报告最终结果以及准备同行评审的数据准确性
审查出版物。
英文摘要
Project Summary/Abstract - Core C:
Core C will provide experienced, well-trained clinical trials staff specializing in implementing translational,
clinical research involving pharmacological ascorbate (P-AscH-). This group of clinical researchers has been
doing clinical trials for the past 10 years and has initiated as well as completed phase 1 and 2 trials using
P-AscH- combined with radiation and/or chemotherapy in pancreas, lung, and GBM subjects. Core C will
initiate, conduct, and complete all aspects of complex human subjects research with P-AscH- which are
proposed in Projects 1 and 2. Core C will also interface with Core B for patient sample acquisition and
processing, for biomarker evaluation as well as establishing a structured training program for staff participating
in each clinical trial research effort. This training program will include instruction in how to review processes for
eligibility determination as well as the review of ascorbate therapy infusions (including administration, review of
and contraindications) and adverse event reporting. In addition, Core C will provide expert guidance and
resources as well as interface with the Holden Comprehensive Cancer Center clinical trials infrastructure [(i.e.,
Protocol Review & Monitoring Committee (PRMC)/ Data and Safety Monitoring Committee (DSMC)] to identify
and report all key research data, and to design electronic case report forms for complete data capture, and to
ensure data veracity for ultimate result reporting to the FDA, and as well as in the preparation of peer-
reviewed publications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core C - Clinical Trials
-
批准号:10005912
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2018
-
负责人:JOHN M. BUATTI
-
依托单位:
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial
-
批准号:8333333
-
项目类别:
-
资助金额:$15.36万
-
财政年份:2011
-
负责人:JOHN M. BUATTI
-
依托单位:
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial
-
批准号:8175225
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2011
-
负责人:JOHN M. BUATTI
-
依托单位:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
-
批准号:8636907
-
项目类别:
-
资助金额:$50.16万
-
财政年份:2010
-
负责人:JOHN M. BUATTI
-
依托单位:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
-
批准号:7891013
-
项目类别:
-
资助金额:$60.72万
-
财政年份:2010
-
负责人:JOHN M. BUATTI
-
依托单位:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
-
批准号:8456899
-
项目类别:
-
资助金额:$49.94万
-
财政年份:2010
-
负责人:JOHN M. BUATTI
-
依托单位:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
-
批准号:8244350
-
项目类别:
-
资助金额:$54.53万
-
财政年份:2010
-
负责人:JOHN M. BUATTI
-
依托单位:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
-
批准号:8964178
-
项目类别:
-
资助金额:$61.75万
-
财政年份:2010
-
负责人:JOHN M. BUATTI
-
依托单位:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
-
批准号:8034225
-
项目类别:
-
资助金额:$56.0万
-
财政年份:2010
-
负责人:JOHN M. BUATTI
-
依托单位:
Deep LOGISMOS
-
批准号:10016301
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2006
-
负责人:JOHN M. BUATTI
-
依托单位:
Deep LOGISMOS
-
批准号:10445034
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2006
-
负责人:JOHN M. BUATTI
-
依托单位:
Deep LOGISMOS
-
批准号:10925774
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2006
-
负责人:JOHN M. BUATTI
-
依托单位:
Deep LOGISMOS
-
批准号:10188526
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2006
-
负责人:JOHN M. BUATTI
-
依托单位:
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER
-
批准号:6414181
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2000
-
负责人:JOHN M. BUATTI
-
依托单位:
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER
-
批准号:6481313
-
项目类别:
-
资助金额:$5.57万
-
财政年份:2000
-
负责人:JOHN M. BUATTI
-
依托单位:
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER
-
批准号:6305533
-
项目类别:
-
资助金额:$3.84万
-
财政年份:1999
-
负责人:JOHN M. BUATTI
-
依托单位:
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER
-
批准号:6276616
-
项目类别:
-
资助金额:$1.94万
-
财政年份:1998
-
负责人:JOHN M. BUATTI
-
依托单位:
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER
-
批准号:6115382
-
项目类别:
-
资助金额:$3.84万
-
财政年份:1998
-
负责人:JOHN M. BUATTI
-
依托单位:
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER
-
批准号:6246551
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1997
-
负责人:JOHN M. BUATTI
-
依托单位:
Core C - Clinical Trials
-
批准号:9788303
-
项目类别:
-
资助金额:$17.08万
-
财政年份:--
-
负责人:JOHN M. BUATTI
-
依托单位:
海外基金